Hearts with hepatitis c: a new hope for transplant patients?

NCT ID NCT04493385

Recruiting now Disease control Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 500 people who received a heart transplant from a donor with hepatitis C. Researchers want to see if using these organs is safe and works well. They will measure cure rates for hepatitis C, organ rejection, and survival after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hepatitis C-positive donor heart
What this could lead to: If successful, this could expand the pool of donor hearts available for transplant, reducing wait times for people with heart failure.
What could go wrong: This is an observational study, not a controlled trial, so results may not prove cause and effect. There are risks of hepatitis C transmission, graft rejection, and other post-transplant complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS C TRANSPLANT; FAILURE, HEART

Contacts and locations

Locations

Baylor Scott & White Health Research Institute
RECRUITING

Dallas, Texas, 75246, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.